Amlodipine Overdose in a Transgender Woman: A Case Study

Calcium channel blockers are a major cause of cardiovascular toxicity. The clinical spectrum of these patients is very variable and there is no consensus on the dose required for toxicity. We present a case of a 43-year-old transgender woman who presented with hypotension and tachycardia owing to dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bojja, Srikaran, Javed, Nismat, Bojja, Shreya, Itare, Vikram, Nasr, Rabih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457432/
https://www.ncbi.nlm.nih.gov/pubmed/37637641
http://dx.doi.org/10.7759/cureus.42511
_version_ 1785096923350302720
author Bojja, Srikaran
Javed, Nismat
Bojja, Shreya
Itare, Vikram
Nasr, Rabih
author_facet Bojja, Srikaran
Javed, Nismat
Bojja, Shreya
Itare, Vikram
Nasr, Rabih
author_sort Bojja, Srikaran
collection PubMed
description Calcium channel blockers are a major cause of cardiovascular toxicity. The clinical spectrum of these patients is very variable and there is no consensus on the dose required for toxicity. We present a case of a 43-year-old transgender woman who presented with hypotension and tachycardia owing to drug overdose that was later confirmed to be amlodipine. Given the catastrophic cascade of events involved with such toxicities, it is important to highlight amlodipine as one of the causes of drug overdose that can be overlooked. 
format Online
Article
Text
id pubmed-10457432
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104574322023-08-27 Amlodipine Overdose in a Transgender Woman: A Case Study Bojja, Srikaran Javed, Nismat Bojja, Shreya Itare, Vikram Nasr, Rabih Cureus Cardiac/Thoracic/Vascular Surgery Calcium channel blockers are a major cause of cardiovascular toxicity. The clinical spectrum of these patients is very variable and there is no consensus on the dose required for toxicity. We present a case of a 43-year-old transgender woman who presented with hypotension and tachycardia owing to drug overdose that was later confirmed to be amlodipine. Given the catastrophic cascade of events involved with such toxicities, it is important to highlight amlodipine as one of the causes of drug overdose that can be overlooked.  Cureus 2023-07-26 /pmc/articles/PMC10457432/ /pubmed/37637641 http://dx.doi.org/10.7759/cureus.42511 Text en Copyright © 2023, Bojja et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiac/Thoracic/Vascular Surgery
Bojja, Srikaran
Javed, Nismat
Bojja, Shreya
Itare, Vikram
Nasr, Rabih
Amlodipine Overdose in a Transgender Woman: A Case Study
title Amlodipine Overdose in a Transgender Woman: A Case Study
title_full Amlodipine Overdose in a Transgender Woman: A Case Study
title_fullStr Amlodipine Overdose in a Transgender Woman: A Case Study
title_full_unstemmed Amlodipine Overdose in a Transgender Woman: A Case Study
title_short Amlodipine Overdose in a Transgender Woman: A Case Study
title_sort amlodipine overdose in a transgender woman: a case study
topic Cardiac/Thoracic/Vascular Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457432/
https://www.ncbi.nlm.nih.gov/pubmed/37637641
http://dx.doi.org/10.7759/cureus.42511
work_keys_str_mv AT bojjasrikaran amlodipineoverdoseinatransgenderwomanacasestudy
AT javednismat amlodipineoverdoseinatransgenderwomanacasestudy
AT bojjashreya amlodipineoverdoseinatransgenderwomanacasestudy
AT itarevikram amlodipineoverdoseinatransgenderwomanacasestudy
AT nasrrabih amlodipineoverdoseinatransgenderwomanacasestudy

Ejemplares similares